Xylem (XYL) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 13.1% | 15.8% | 15.2% | 19.8% | 19.8% | 19.8% | ||
| Changes by years, y/y, % | +2pp | +3pp | -1pp | +5pp | 0pp | +5.5% | |||
Xylem. EBITDA margin, %
Xylem. EBITDA margin, changes, pp
Xylem (XYL) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 17.9% | 19.7% | 19.6% | 21.6% | 18.3% | 19.8% | |
| Changes by years, y/y, % | +1pp | +1pp | 0pp | -2pp | +0pp | |||
| Changes by quarters, q/q, % | -5pp | +2pp | 0pp | +2pp | -3pp | |||